Yokoyama Akira, Yokoyama Tetsuji, Mizukami Takeshi, Matsui Toshifumi, Kimura Mitsuru, Matsushita Sachio, Higuchi Susumu, Maruyama Katsuya
Corresponding author:
Alcohol Alcohol. 2014 Jan-Feb;49(1):31-7. doi: 10.1093/alcalc/agt136. Epub 2013 Aug 21.
Genetic polymorphisms of alcohol dehydrogenase-1B (ADH1B, rs1229984) and aldehyde dehydrogenase-2 (ALDH2, rs671) affect ethanol (EtOH) metabolism and susceptibility to alcoholism.
We evaluated associations between ADH1B/ALDH2 genotypes and the blood EtOH levels of 805 Japanese alcoholic men in the morning after they had drunk within the previous 34 h.
Age-adjusted usual alcohol consumption did not differ according to ADH1B/ALDH2 genotypes. Higher blood EtOH levels persisted for longer periods in the ADH1B1/1 carriers (n = 246) than in the ADH1B2 carriers (n = 559). Blood EtOH levels did not differ by ALDH2 genotype. The blood EtOH levels ≥ 0.3 mg/ml (criterion for drunk driving in Japanese law) were observed (40% vs. 14-17%, P < 0.0001) in a higher proportion of the ADH1B1/1 carriers than of the ADH1B2 carriers after a 12.1-to-18-h interval since the last drink. Multivariate analyses showed that the EtOH levels heightened by 0.500 mg/ml in the presence of ADH1B11 and by 0.248 mg/ml in the presence of cirrhosis, and lowered by 0.120 mg/ml per 10-year age increase, by 0.087 mg/ml per 10-kg body-weight increase and by 0.673 mg/ml per 10-h interval since the last drink. The odds ratio (95% confidence interval) for an EtOH level ≥ 0.3 mg/ml was 3.44 (2.34-5.04) in the presence of ADH1B*1/*1, 2.01 (1.28-3.14) in the presence of cirrhosis, 0.59 (0.49-0.71) per 10-year age increase, 0.80 (0.68-0.95) per 10-kg body-weight increase and 0.10 (0.07-0.15) per 10-h interval since the last drink.
The longer-than-expected EtOH lingering in the blood of the ADH1B*1/*1 alcoholics may exacerbate alcohol-related problems, including drunk driving.
乙醇脱氢酶-1B(ADH1B,rs1229984)和乙醛脱氢酶-2(ALDH2,rs671)的基因多态性会影响乙醇(EtOH)代谢以及酒精中毒易感性。
我们评估了805名日本男性酗酒者的ADH1B/ALDH2基因型与他们在前34小时内饮酒后次日早晨血液中EtOH水平之间的关联。
经年龄调整后的日常酒精摄入量在不同ADH1B/ALDH2基因型之间并无差异。ADH1B1/1携带者(n = 246)血液中较高的EtOH水平持续时间比ADH1B2携带者(n = 559)更长。血液EtOH水平在不同ALDH2基因型之间并无差异。在最后一次饮酒后的12.1至18小时间隔后,ADH1B1/1携带者血液中EtOH水平≥0.3 mg/ml(日本法律规定的酒驾标准)者的比例更高(40% 对14 - 17%,P < 0.0001)。多因素分析显示,存在ADH1B11时EtOH水平升高0.500 mg/ml,存在肝硬化时升高0.248 mg/ml,年龄每增加10岁降低0.120 mg/ml,体重每增加10 kg降低0.087 mg/ml,自最后一次饮酒起每间隔10小时降低0.673 mg/ml。EtOH水平≥0.3 mg/ml时的比值比(95%置信区间)在存在ADH1B1/*1时为3.44(2.34 - 5.04),存在肝硬化时为2.01(1.28 - 3.14),年龄每增加10岁为0.59(0.49 - 0.71),体重每增加10 kg为0.80(0.68 - 0.95),自最后一次饮酒起每间隔10小时为0.10(0.07 - 0.15)。
ADH1B*1/*1酗酒者血液中EtOH持续时间长于预期,可能会加重包括酒驾在内的与酒精相关的问题。